Clinical Trials Browser

Phase NA × Leukemia × Interleukin-2 × Clear all

NCT01517347 2016-10-24

Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation

Phase NA Terminated

Other hematologic neoplasm

Leukemia, Recurrence

NCT00187096 2014-06-19

Natural Killer (NK) Cell Transplantation for AML

Phase NA Completed

49 enrolled 17 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute